ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Ardelyx, Inc. due to a class action complaint alleging breaches of fiduciary duties by the board of directors following a significant stock price drop after the company announced it would not apply to include XPHOZAH in TDAPA as previously indicated [1][2]. Company Summary - Ardelyx, Inc. is facing legal scrutiny from shareholders after a class action complaint was filed on August 16, 2024, concerning the period from October 31, 2023, to July 1, 2024 [1]. - The complaint highlights that Ardelyx had previously stated its intent to apply for XPHOZAH's inclusion in TDAPA in its Forms 10-Q and 10-K, but later retracted this statement on July 2, 2024, leading to a significant drop in stock price [1]. - Following the announcement on July 2, 2024, Ardelyx's stock price fell by $2.29 per share, or 30.25%, closing at $5.28 per share [2].